Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ischaemic hepatitis in the elderly.

Khalid A Rashed1, W Robin McNabb, Roger R Lewis

  • 1Department of Geriatric and General Medicine, Guy's and St. Thomas' Hospital Trust, London, UK.

Gerontology
|June 8, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vinpocetine alleviated alveolar epithelial cells injury in experimental pulmonary fibrosis by targeting PPAR-γ/NLRP3/NF-κB and TGF-β1/Smad2/3 pathways.

Scientific reports·2024
Same author

Association of ACE1 I/D polymorphism and susceptibility to COVID-19 in Egyptian children and adolescents.

Pediatric research·2024
Same author

The relationship between acute ischaemic stroke and plasma D-dimer levels in patients developing neither venous thromboembolism nor major intercurrent illness.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis·2003
Same author

Pulmonary embolism and pneumonia may be confounded after acute stroke and may co-exist.

Age and ageing·2002
Same author

Anticoagulation in acute pulmonary embolism.

Archives of internal medicine·2002
Same author

Mortality from pulmonary embolism after acute stroke: can we do better?

Age and ageing·2002

Ischaemic hepatitis, a liver condition linked to cardiovascular events, occurs in 1% of elderly hospital patients. Prompt recognition and management are crucial, as a third of affected patients may die.

Area of Science:

  • Geriatric Medicine
  • Hepatology
  • Cardiology

Background:

  • Ischaemic hepatitis, characterized by centrilobular necrosis, is often associated with acute cardiovascular events.
  • It is considered rare in general hospitals but frequently unrecognized, impacting patient investigations and drug therapy.
  • Previous research has not specifically addressed ischaemic hepatitis in the elderly population.

Purpose of the Study:

  • To determine the incidence of ischaemic hepatitis in elderly patients admitted to a Geriatric Medicine department.
  • To assess the clinical and biochemical features of ischaemic hepatitis in this demographic.

Main Methods:

  • Prospective assessment of 1,905 consecutive elderly patients (age ≥65 years) over two years.
  • Diagnosis of ischaemic hepatitis based on rapid hepatocellular liver function test abnormalities in acutely ill patients with a blood pressure fall, excluding other causes.

Related Experiment Videos

  • Monitoring of blood pressure, daily liver and renal function tests, and prothrombin times during acute illness.
  • Main Results:

    • Ischaemic hepatitis developed in 19 patients (1%), most commonly linked to left ventricular failure.
    • Significant drops in blood pressure (systolic, diastolic, mean) were observed.
    • Marked elevations in alanine aminotransferase and lactic dehydrogenase were noted, with normalization within 7-22 days in survivors. Prolonged prothrombin times (>20s) occurred in 32% of patients.
    • Six patients died, primarily from left ventricular failure, with elevated creatinine and urea levels in non-survivors.

    Conclusions:

    • Ischaemic hepatitis is an uncommon but significant condition in acutely admitted elderly patients.
    • The study observed a dramatic rise in liver enzymes, which normalized within three weeks in survivors.
    • Clinical presentation was dominated by the underlying cause, and mortality was substantial, with one-third of patients dying.